FDA Inspection 1266873 — Tongling Jieya Biologic Technology Stock Co., Ltd.
The FDA completed an inspection of Tongling Jieya Biologic Technology Stock Co., Ltd. on March 21, 2025 in Tongling. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tongling (China)